DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen Inc., (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that multiple abstracts have been accepted for oral and poster presentations at the 100th Annual Meeting of the American Association for Cancer Research (AACR), which will take place April 18-22 in Denver, Colorado.
